中医小儿推拿治疗儿童急性腹泻:随机假推拿对照试验研究方案
本研究为随机双盲假推拿对照试验方案,计划纳入广东省东莞康华医院0-6岁急性腹泻患儿122例,按1:1分配至小儿推拿组或假推拿组,两组均接受常规护理,治疗3天并随访11天。主要结局为基线起腹泻天数及第3天腹泻次数,旨在评估中医小儿推拿治疗儿童急性腹泻的疗效与安全性。
要点
- 试验采用随机双盲假推拿对照设计,计划纳入122例0-6岁急性腹泻患儿。
- 两组均接受常规护理,推拿组加用15-25分钟中医小儿推拿,每日1次连续3天。
- 主要结局为基线起腹泻天数与第3天腹泻次数,随访共11天。
核心结论
- 该试验旨在评估中医小儿推拿对0-6岁急性腹泻患儿的疗效,预期为小儿推拿作为适宜治疗提供可靠证据支持。
研究设计与样本
- 研究为随机、双盲、假推拿对照试验,计划纳入广东省东莞康华医院0-6岁急性腹泻患儿122例。
- 患儿按1:1比例分配至小儿推拿组或假推拿组,两组均接受常规护理。
- 治疗持续3天,随后进行11天随访期;两组均每日治疗1次,连续3天。
- 试验注册于ClinicalTrials.gov,注册号NCT03005821,注册日期2016年12月29日。
关键数值与推荐
- 主要结局指标为基线起腹泻天数及第3天腹泻次数。
- 次要结局指标为整体变化评分及大便性状转为正常所需天数。
- 推拿组接受15-25分钟中医小儿推拿,对照组接受15-25分钟假小儿推拿。
- 每次访视时进行安全性评估。
临床怎么用
- 若试验证实有效,小儿推拿或可作为0-6岁急性腹泻患儿的辅助治疗选择,但需结合常规护理。
局限性
- 本文件为研究方案,尚未报告实际疗效与安全性结果。
- 样本仅来自单家医院,纳入0-6岁患儿,外推需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Acute pediatric diarrhea is one of the most common causes of morbidity and mortality worldwide and seriously affects the health of children. Previous studies have shown that pediatric Tuina, a traditional Chinese medicine therapy, has potential therapeutic benefits for acute pediatric diarrhea. However, the evidence for its effectiveness is insufficient due to the lack of high-quality clinical studies. Our aim is to evaluate the efficacy of Chinese pediatric Tuina for children aged 0-6 years with acute diarrhea. METHODS/DESIGN: This study is a randomized, double-blind, sham-controlled trial. We will include 122 children with acute diarrhea from Dongguan Kanghua Hospital in Guangdong province, China. The patients will be allocated into either the pediatric Tuina group or the sham Tuina group in a 1:1 ratio. The treatment will last for 3 days followed by an 11-day follow-up period. Both groups will receive usual care. In addition, the experimental group will receive 15-25 min of Chinese pediatric Tuina, while the control group will receive 15-25 min of sham pediatric Tuina. Both groups will receive treatments once per day, for 3 consecutive days. Primary outcome measures are diarrhea days from baseline and diarrhea times on the third day. Secondary outcome measures are the global change rating and period of days when the stool character changes to normal. Safety assessments will be monitored during each visit. DISCUSSION: This clinical trial is designed to evaluate the efficacy of pediatric Tuina for children with acute diarrhea. We expect results to provide solid evidence and support for pediatric Tuina as an appropriate treatment for children with acute diarrhea. TRIAL REGISTRATION: ClinicalTrials.gov, NCT03005821. Registered on 29 December 2016.
引用
- Lu T, Zhang H, Yin L, et al. Chinese pediatric Tuina on children with acute diarrhea: study protocol for a randomized sham-controlled trial. Trials. 2019. PMID: 31815655. doi:10.1186/s13063-019-3818-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。